Real-time enrollment status for this small cell lung cancer clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 9:49 PM UTC
| NCT Number | NCT06801834 |
| Recruiting Status | Recruiting |
| Condition | Small Cell Lung Cancer |
| Phase | PHASE3 |
| Target Enrollment | 695 participants |
| Active Locations | 23 sites in the US |
| Sponsor | Gilead Sciences |
| Last Updated on CT.gov | August 12, 2026 (2 weeks ago) |
As of August 31, 2026: Clinical trial NCT06801834 is currently recruiting participants. This phase3 study for small cell lung cancer is actively seeking new participants at 23 locations across the United States. The study is sponsored by Gilead Sciences. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06801834 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 23 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06801834 was last updated 2 weeks ago (August 12, 2026). HelloStudys verifies this status automatically.